Skip to content

Clinical trials

Phase 3 Multiple Sclerosis, Chronic Progressive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Chronic Progressive Phase: Phase 3 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20081
20113
20121
20133
20151
20162
20183
20191
20204
20211
20222
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting6
Terminated6
Recruiting4
Unknown status2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Biogen3
Novartis Pharmaceuticals3
AB Science2
MedDay Pharmaceuticals SA2
Sanofi2
Zenas BioPharma (USA), LLC2
Assistance Publique - Hôpitaux de Paris1
Bayer1
BioMS Technology Corp.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Chronic Progressive30
Multiple Sclerosis12
Multiple Sclerosis, Relapsing-Remitting5
Neoplasm Metastasis1
Optic Neuritis1
Recurrence1
Vision Disorders1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.